Articles

Homeopathic Industry Proposes More Broad Use of Disclosures to FTC as the Path Forward

September 22, 2015

Industry leaders provide perspective on partnership opportunities for Federal Trade Commission Washington, D.C., Sept. 21, 2015— To better help consumers make informed choices, the American Association of Homeopathic Pharmacists (AAHP) proposed strengthening product label and advertising disclosures to the Federal Trade Commission (FTC) today in Washington, D.C. at the agency’s “Homeopathic Medicine & Advertising” workshop.…

The Homeopathic Industry Needs YOUR Support

August 3, 2015

Over the past few decades, the homeopathic industry has grown into a multibillion-dollar industry and national drug stores are finally recognizing the merits of our product. But as the industry has grown, so, too, has skepticism from legislators and regulators. While we successfully argued for the effectiveness of current regulations at a FDA hearing a few months…

Speakers at FDA Hearing Praise Success of Homeopathic Regulatory Framework

May 14, 2015

Silver Spring, Md., April 20, 2015—The American Association of Homeopathic Pharmacists (AAHP) today told the U.S. Food and Drug Administration that the agency’s regulatory policy for homeopathic medicines has worked effectively for the last 25 years to protect the public health and provide consumer access to safe homeopathic medicines. AAHP, the industry’s trade association, was…

AAHP Response to Australian Study on Homeopathic Effectiveness

March 24, 2015

National Health and Medical Research Council (NHMRC) Information Paper: Evidence on the effectiveness of homeopathy for treating health conditions On March 11, 2015, the Australian National Health and Medical Research Council (NHMRC) released an information paper and announcement regarding evidence on the effectiveness of homeopathy for treating health conditions. The American Association of Homeopathic Pharmacists…

FDA’s Quality Metrics Initiative – From Compliance to Performance

February 17, 2015

By Mark Land, VP Operations and Regulatory Affairs at Boiron The 2012 Food Drug Administration Safety and Innovation Act (FDASIA) gave FDA new tools to encourage high quality manufacturing of pharmaceuticals and enhanced the agency’s ability to respond to, prevent and mitigate the risk of drug shortages. Section 705 of the Act specifically requires FDA…

Stability Testing

February 17, 2015

The AAHP office just received a copy of an article, Stability Testing of Medicinal Products According to Homeopathic Principles; this appeared in Pharmaceutical Industry (71, Nr. 12). The article was co-written by 8 colleagues of European companies, of which 5 are members, or related to members, of the AAHP. The article addresses the implementation, in…

Deployment of FDA Inspection Resources

January 23, 2015

This content is restricted to AAHP members. If you are a member, please login. If you are not a member, click here.Existing Users Log InUsername or EmailPassword Remember Me  

Publications Review – A Treasure Source

December 19, 2014

AAHP Board member Mary Beth Watkins notes two periodicals containing articles that may be of interest to industry members. In the American Journal of Homeopathic Medicine (Vol. 107, No 3, Autumn 2014), we find the wonderful news regarding an award given to long time AAHP Member, John A (Jack) Borneman, III. In addition, H1N1 Influenza: A…

Change, Growth, and Successes

December 19, 2014

The past 12 months have been one of change, growth and successes for the American Association of Homeopathic Pharmacists. These continued the positive achievements of the association during the 90th anniversary year of 2013. January 2014 saw the introduction of  a new logo for the AAHP that was the result of a collaborative effort on…

Assays of homeopathic preparations

December 19, 2014

This content is restricted to AAHP members. If you are a member, please login. If you are not a member, click here.Existing Users Log InUsername or EmailPassword Remember Me  

Leave a Comment

You must be logged in to post a comment.